Social Media Ideas for Precision Medicine

Genetic medicine luminaries launch new center for personalized therapies

A team of veteran scientists from elite institutions has come together to form a new center dedicated to the crafting of personalized genetic medicines, adding to the growing list...

Precision Medicine Transformed Oncology —It’s Time to Do the Same for Sepsis

It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable.  The post Precision Medicine Transformed...

McKesson strikes $2.25B deal to snap up Precision Medicine Group

The healthcare conglomerate, which ranks eighth on the Fortune 500 list, is set to envelop privately held Precision Medicine Group into its oncology branch as part of an ongoing ef...

Patient-Derived Tumor Organoids Show Promise for Personalizing Cancer Treatment

Researchers developed a 220-sample pan-cancer patient-derived organoid platform that faithfully mirrors tumors, identifies new treatment opportunities, and advances precision oncol...

A genomic-led strategy to anticipate drug safety effects

by Brian R. Ferolito, Andrea R. V. R. Horimoto, Kai Gravel-Pucillo, Daniel J. Golden, Hesam Dashti, Claudia Giambartolomei, Danielle Rasooly, Rachael Matty, Liam Gaziano, Yakov Tse...

Multi-omics map paves way for personalized medicine in Down syndrome

In a recent study published in Nature Communications, researchers from the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome (Crnic Institute) discovered uniq...

Tempus AI: Winning With Precision Medicine

An AI drug specialist zeroes in on rare forms of obesity

Superluminal Medicines banked $60 million in funding to support development of a drug designed to work similarly to — but potentially more selectively than — Rhythm Pharmaceuticals...

A framework linking polygenic risk to precision gynecological disease models

Precision medicine has transformed the way clinicians approach some forms of cancer, but for the vast majority of gynecological disorders — from endometriosis and polycystic ovary...

Rewriting Disease: Oligonucleotides Take Aim at the Untreatable

How synthetic DNA and RNA are becoming the discovery engines behind a new generation of precision therapies. The post Rewriting Disease: Oligonucleotides Take Aim at the Untreatabl...

Why the future of clinical trials depends on understanding patients, not just drugs

The history of medicine is filled with remarkable scientific breakthroughs. Yet many promising therapies that perform exceptionally in laboratories and animal models fail to delive...

Cardinal Health: Precision Medicine Drives A Sustained Revenue Growth Path

Interactive: A cancer vaccine is being tailored to individuals

Moderna and Merck say their personalized mRNA therapy showed positive results in a major Phase 3 trial — potentially changing how America treats one of its deadliest skin cancers.

Precision healthcare could be Taiwan’s strength

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines

The PROPEL program aims to control gene expression through RNA structure, building logic-gated RNA therapies that switch on only where and when intended, without altering the genom...

<![CDATA[M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Part...

Novel Epigenetic Therapy Targets Treatment-Resistant and TP53-Mutant AML

The results of a preclinical study across multiple models of acute myeloid leukemia found that the investigational hypomethylating agent, NTX-301 remained effective in treatment-re...

Personalized Medicine and the Future of Hormone Optimization

Concierge medicine was built on a simple premise: healthcare works better when a physician has the time, access, and continuity to actually know their patient, rather than triaging...

Imagene AI and Tel Aviv Sourasky University Medical Center (Ichilov) Build Clinical AI Infrastructure to Advance Precisi...

The collaboration will enable the development, validation, and application of advanced AI technologies to identify clinically meaningful patient subgroups, support biomarker-driven...

Not Yet AI Curing Cancer But Validating Gains Can Be Made

The Moderna Neoantigen selection. A tumor carries thousands of mutations. Only a handful produce peptides that get presented on MHC and recognized by T cells. Moderna’s pipeline ta...

GLP-1 drugs could become personalized for individuals, study says

The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.

Merck, Moderna Personalized mRNA Cancer Therapy Achieves a First for Melanoma

Merck and Moderna said intismeran autogene, an mRNA cancer vaccine that prompts an immune response to proteins expressed by a patient’s tumors, met the main goal of a pivotal test...

The Coming Shift from Biomarkers to Biological Trajectories

The next era of medicine will not be defined by earlier detection alone, but by understanding dynamics. The post The Coming Shift from Biomarkers to Biological Trajectories appeare...

Cure Childhood Cancer is changing the fight with precision medicine

Founded in 1975, Cure Childhood Cancer funds pediatric cancer research. Today, Cure’s major focus is precision medicine—a cutting-edge approach that uses patients’ genetic profiles...